Business Description
Syngene International Ltd
ISIN : INE398R01022
Total Employee Number:
6,533Compare
Compare
Traded in other countries / regions
539268.India Index Membership
NIFTY 500 IPO Date
2015-08-11Description
Syngene International Ltd is a contract research, development and manufacturing organization (CRDMO) providing integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies. Its business divisions include Discovery Services, Translational & Clinical Research, Dedicated Centers, and Contract Development and Manufacturing Services. Its services cover lead generation, medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development, and clinical development services. The Company operates in a single segment of contract research and manufacturing services, with the majority of its revenue derived from the USA.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.81 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 0.58 | |||||
Interest Coverage | 13.7 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.8 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.5 | |||||
3-Year EBITDA Growth Rate | -2.9 | |||||
3-Year EPS without NRI Growth Rate | -5.3 | |||||
3-Year FCF Growth Rate | 21.6 | |||||
3-Year Book Growth Rate | 10 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 22.31 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.33 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 19.81 | |||||
9-Day RSI | 24.87 | |||||
14-Day RSI | 29.1 | |||||
3-1 Month Momentum % | -6.02 | |||||
6-1 Month Momentum % | -7.17 | |||||
12-1 Month Momentum % | -38.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.38 | |||||
Quick Ratio | 1.29 | |||||
Cash Ratio | 0.83 | |||||
Days Inventory | 67.64 | |||||
Days Sales Outstanding | 52.99 | |||||
Days Payable | 137.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.32 | |||||
Dividend Payout Ratio | 0.17 | |||||
3-Year Dividend Growth Rate | 35.7 | |||||
Forward Dividend Yield % | 0.32 | |||||
5-Year Yield-on-Cost % | 0.31 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 0.87 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 75.71 | |||||
Operating Margin % | 17.81 | |||||
Net Margin % | 6.14 | |||||
EBITDA Margin % | 21.97 | |||||
FCF Margin % | 15.19 | |||||
OCF Margin % | 25.42 | |||||
ROE % | 4.64 | |||||
ROA % | 3.25 | |||||
ROIC % | 8.76 | |||||
3-Year ROIIC % | -3.17 | |||||
ROC (Joel Greenblatt) % | 8.45 | |||||
ROCE % | 6.22 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 70.25 | |||||
Forward PE Ratio | 41.26 | |||||
PE Ratio without NRI | 51 | |||||
Shiller PE Ratio | 32.46 | |||||
Price-to-Owner-Earnings | 25.93 | |||||
PEG Ratio | 9.11 | |||||
PS Ratio | 4.33 | |||||
PB Ratio | 3.2 | |||||
Price-to-Tangible-Book | 3.23 | |||||
Price-to-Free-Cash-Flow | 28.39 | |||||
Price-to-Operating-Cash-Flow | 16.97 | |||||
EV-to-EBIT | 43.57 | |||||
EV-to-EBITDA | 18.57 | |||||
EV-to-Revenue | 4.08 | |||||
EV-to-FCF | 26.86 | |||||
Price-to-GF-Value | 0.53 | |||||
Price-to-Projected-FCF | 1.93 | |||||
Price-to-DCF (Earnings Based) | 5.08 | |||||
Price-to-DCF (FCF Based) | 1.19 | |||||
Price-to-Median-PS-Value | 0.51 | |||||
Price-to-Graham-Number | 2.39 | |||||
Earnings Yield (Greenblatt) % | 2.3 | |||||
FCF Yield % | 3.52 | |||||
Forward Rate of Return (Yacktman) % | 7.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syngene International Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 36,002 | ||
| EPS (TTM) (₹) | 5.49 | ||
| Beta | 1.2572 | ||
| 3-Year Sharpe Ratio | -0.59 | ||
| 3-Year Sortino Ratio | -0.72 | ||
| Volatility % | 39.66 | ||
| 14-Day RSI | 29.1 | ||
| 14-Day ATR (₹) | 13.250424 | ||
| 20-Day SMA (₹) | 413.3475 | ||
| 12-1 Month Momentum % | -38.45 | ||
| 52-Week Range (₹) | 375.25 - 714.35 | ||
| Shares Outstanding (Mil) | 402.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syngene International Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syngene International Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2027 | 2027-01-22 14:00 | In 175 days | ||
| Third quarter earnings results for 2027 | 2027-01-22 | In 174 days | ||
| Second quarter earnings conference call for 2027 | 2026-11-06 14:00 | In 98 days | ||
| Second quarter earnings results for 2027 | 2026-11-06 | In 97 days | ||
| First quarter earnings conference call for 2027 | 2026-07-30 09:00 | 414.25 (+0.33%) | ||
| First quarter earnings results for 2027 | 2026-07-30 | 414.25 (+0.33%) | ||
| General meeting for 2026 | 2026-07-29 15:30 | 409.15 (-1.17%) | ||
| Annual report for 2026 | 2026-07-02 | 431.55 (-2.58%) | ||
| INR 1.250000 Cash Dividend | 2026-06-25 | 442.95 (+0.84%) | ||
| Fourth quarter earnings conference call for 2026 | 2026-04-30 14:00 | 432.15 (-1.84%) |
Show
Entries
Syngene International Ltd Frequently Asked Questions
What is Syngene International Ltd(NSE:SYNGENE)'s stock price today?
The current price of NSE:SYNGENE is ₹385.90. The 52 week high of NSE:SYNGENE is ₹714.35 and 52 week low is ₹375.25.
When is next earnings date of Syngene International Ltd(NSE:SYNGENE)?
The next earnings date of Syngene International Ltd(NSE:SYNGENE) is 2026-11-06 Est..
Does Syngene International Ltd(NSE:SYNGENE) pay dividends? If so, how much?
The Dividend Yield %  of Syngene International Ltd(NSE:SYNGENE) is 0.32% (As of Today), Highest Dividend Payout Ratio of Syngene International Ltd(NSE:SYNGENE) was 0.17. The lowest was 0.04. And the median was 0.06. The  Forward Dividend Yield % of Syngene International Ltd(NSE:SYNGENE) is 0.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Syngene International Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers